Impact of CYP2D6 on venlafaxine metabolism in Trinidadian patients with major depressive disorder.

Home
Find People
Find Everything
About This Site
Annual Report
Export RDF

Impact of CYP2D6 on venlafaxine metabolism in Trinidadian patients with major depressive disorder.

Montan? Jaime LK, Paul J, Lalla A, Legall G, Gaedigk A. Impact of CYP2D6 on venlafaxine metabolism in Trinidadian patients with major depressive disorder. Pharmacogenomics. 2018 02; 19(3):197-212.

View in: PubMed

subject areas

Adult
Cytochrome P-450 CYP2D6
Depressive Disorder, Major
Female
Gene Frequency
Genotype
Humans
Indians, South American
Male
Polymorphism, Single Nucleotide
Serotonin and Noradrenaline Reuptake Inhibitors
Trinidad and Tobago
Venlafaxine Hydrochloride

authors with profiles

Andrea Gaedigk